Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Imara, Inc.
3161
Imara, Inc.
Technology
Biotechnology
Health Care
Medical
Therapeutics
Imara is dedicated to advancing new therapies to improve the lives of people living with sickle cell disease and other hemoglobinopathies.
Suggest edits
Type
B2c
Founded
2015
Raised
$63M
Follow us
Also headquartered in Cambridge
MIT
Raspberry Pi
ARM
Xconomy
Biogen
Money Mover
HubSpot
Formlabs
Akamai
General Catalyst
Companies in the same industry
ELSALYS BIOTECH
Kyn Therapeutics
Edgewise Therapeutics
Fountain Therapeutics
TARA Biosystems
Centauri Therapeutics Limited
TapImmune
Aspyrian Therapeutics
Blueberry Therapeutics Ltd
ImStar Therapeutics
Alexa global traffic share
Twitter followers
Overview
Funding
1
Add info
Latest funding
$63,000,000
Venture capital (Series B) - 2019
OrbiMed
Team Size
1–10
Employees
I work here
Location
Cambridge
,
United States
Headquarters
Explore Cambridge
Xconomy
Imara Dives Into Coronavirus-Churned Financial Waters With a $75M IPO
Xconomy
Imara Reveals IPOs Plan as Sickle Cell Drug Advances in the Clinic
